Senior insider sale
See Remarks at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$448.8K
24.40K shares
What this filing means
WARMUTH MARKUS plans to sell 24.40K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $448.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001965301-26-000066
DirectorOfficer· See Remarks
Since Jun 2021
24.40K
Shares to sell
$448.8K
Approx. market value
21.86K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Award
Compensation
1/2/2025
21.86KTotal acquired21.86K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | Stock Award Compensation | 21.86K | — |
| Total | 21.86K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5.47K
Market value
$103.4K
5/1/2026
—Completed
Units to sell
8K
Market value
$141.1K
4/14/2026
—Completed
Units to sell
5.47K
Market value
$98.0K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.47K
Market value
$106.3K
6/1/2026
Total
Units
24.40K
Value
$448.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 5.47K | $103.4K | — | Completed |
4/14/2026 | 8K | $141.1K | — | Completed |
3/2/2026 | 5.47K | $98.0K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 5.47K | $106.3K | NASDAQ | Planned |
| Total | 24.40K | $448.8K | ||